Biopharmaceutical Firm Candel Therapeutics Prices Downsized US$72 Million IPO

Late clinical stage biopharmaceutical company Candel Therapeutics Inc. (Nasdaq: CADL) started publicly trading on the Nasdaq Global Market today under the symbol “CADL”. The firm’s initial public offering is looking to raise US$72.0 million and is expected to close on July 29, 2021.

The offering will be conducted through the issuance of 9,000,000 common shares selling at US$8.00 per share. This is an adjustment from the company’s original plan to issue 6.1 million shares with share price expectations between US$13.00 and US$15.00.

The company granted a 30-day over-allotment option to purchase additional 1,350,000 common shares at the same IPO price, potentially bringing proceeds up to US$82.8 million. Jefferies, Credit Suisse, BMO Capital Markets, and UBS Investment Bank are all acting as joint bookrunners for the said offering.

Selkirk Copper Mines — sponsored Sponsored · Selkirk Copper Mines

The Massachusetts-based biotech firm is in the business of developing novel oncolytic viral immunotherapies to treat patients with cancer, inducing “immunogenic cell death in cancer cells at the site of injection”. Currently, Candel Therapeutics has immunotherapy platforms in its portfolio –the lead adenovirus platform product candidate CAN-2409 and the lead HSV platform product candidate CAN-3310.


Information for this briefing was found via Sedar and Candel Therapeutics. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Inside a Forgotten High-Grade Gold Mine in the Yukon | Blue Jay Gold [DD-on-the-GO Ep. 10]

WHICH MINING STOCKS CAN STILL RUN? | Mining Stock Mailbag [Nov. 9-13]

Silver’s Bull Market Isn’t Over | Peter Krauth

Recommended

Epic Gold Delivers Maiden 279,000 Ounce Inferred Resource at Wilson Project

First Phosphate Adds UK Export Finance to Growing Export Credit Lineup With C$220 Million Letter of Interest

Related News

Russian Real Estate Platform Cian Prices US$291 Million NYSE IPO

Online real estate classified ad platform Cian PLC (NYSE: CIAN) started trading on the New...

Monday, November 8, 2021, 02:17:00 PM

Green Energy SPAC ClimateRock Prices US$75 Million IPO

Special purpose acquisition company ClimateRock (Nasdaq: CLRCU) started trading publicly on the Nasdaq Global Market...

Friday, April 29, 2022, 02:22:00 PM

Tech SPAC Aurora Technology Acquisition Prices US$200 Million IPO

Special purpose acquisition company Aurora Technology Acquisition Corp. (Nasdaq: ATAKU) started trading publicly on the...

Tuesday, February 8, 2022, 02:26:00 PM

Anthropic Files Confidential S-1 as AI IPO Wave Nears $3 Trillion

Anthropic, the public benefit corporation behind Claude, filed a confidential S-1 registration statement with the...

Tuesday, June 2, 2026, 04:55:12 AM

India-Focused Tech SPAC Cartica Acquisition Prices US$200 Million IPO

Special purpose acquisition company Cartica Acquisition Corp. (Nasdaq: CITEU) started trading on the Nasdaq Global...

Wednesday, January 5, 2022, 02:17:00 PM